Annual Shareholders Equity
$93.11 M
-$24.01 M-20.50%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual stockholders equity is currently $93.11 million, with the most recent change of -$24.01 million (-20.50%) on 31 December 2023. During the last 3 years, it has fallen by -$63.26 million (-40.46%). LXRX annual shareholders equity is now -68.71% below its all-time high of $297.57 million, reached on 31 December 2011.LXRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$178.51 M
-$61.47 M-25.61%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly stockholders equity is currently $178.51 million, with the most recent change of -$61.47 million (-25.61%) on 30 September 2024. Over the past year, it has increased by +$39.00 million (+27.96%). LXRX quarterly shareholders equity is now -44.02% below its all-time high of $318.90 million, reached on 31 March 2010.LXRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.5% | +28.0% |
| 3 y3 years | -40.5% | +30.7% |
| 5 y5 years | +452.6% | +8.4% |
LXRX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -40.5% | at low | -38.2% | +152.0% |
| 5 y | 5 years | -40.5% | +452.6% | -38.2% | +1770.4% |
| alltime | all time | -68.7% | +452.6% | -44.0% | +375.1% |
Lexicon Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $178.51 M(-25.6%) |
| June 2024 | - | $239.98 M(-16.9%) |
| Mar 2024 | - | $288.87 M(+210.2%) |
| Dec 2023 | $93.11 M(-20.5%) | $93.11 M(-33.3%) |
| Sept 2023 | - | $139.51 M(-25.1%) |
| June 2023 | - | $186.36 M(+111.7%) |
| Mar 2023 | - | $88.05 M(-24.8%) |
| Dec 2022 | $117.12 M(+3.1%) | $117.12 M(-18.7%) |
| Sept 2022 | - | $144.02 M(+103.3%) |
| June 2022 | - | $70.83 M(-23.6%) |
| Mar 2022 | - | $92.70 M(-18.4%) |
| Dec 2021 | $113.59 M(-27.4%) | $113.59 M(-16.8%) |
| Sept 2021 | - | $136.60 M(-0.5%) |
| June 2021 | - | $137.23 M(-10.0%) |
| Mar 2021 | - | $152.55 M(-2.4%) |
| Dec 2020 | $156.37 M(+33.5%) | $156.37 M(+78.4%) |
| Sept 2020 | - | $87.64 M(-920.1%) |
| June 2020 | - | -$10.69 M(-119.5%) |
| Mar 2020 | - | $54.78 M(-53.2%) |
| Dec 2019 | $117.10 M(-543.5%) | $117.10 M(-28.9%) |
| Sept 2019 | - | $164.71 M(-353.8%) |
| June 2019 | - | -$64.89 M(+42.0%) |
| Mar 2019 | - | -$45.69 M(+73.0%) |
| Dec 2018 | -$26.41 M(-138.7%) | -$26.41 M(-10.2%) |
| Sept 2018 | - | -$29.40 M(+479.8%) |
| June 2018 | - | -$5.07 M(-119.4%) |
| Mar 2018 | - | $26.19 M(-61.6%) |
| Dec 2017 | $68.27 M(-56.6%) | $68.27 M(-12.9%) |
| Sept 2017 | - | $78.38 M(-26.3%) |
| June 2017 | - | $106.31 M(-21.0%) |
| Mar 2017 | - | $134.60 M(-14.5%) |
| Dec 2016 | $157.40 M(-44.9%) | $157.40 M(-15.0%) |
| Sept 2016 | - | $185.18 M(-14.8%) |
| June 2016 | - | $217.33 M(-14.1%) |
| Mar 2016 | - | $252.88 M(-11.5%) |
| Dec 2015 | $285.85 M(+0.6%) | $285.85 M(+44.4%) |
| Sept 2015 | - | $197.94 M(-14.5%) |
| June 2015 | - | $231.47 M(-10.1%) |
| Mar 2015 | - | $257.61 M(-9.3%) |
| Dec 2014 | $284.02 M(+66.9%) | $284.02 M(+264.9%) |
| Sept 2014 | - | $77.82 M(-33.3%) |
| June 2014 | - | $116.67 M(-17.1%) |
| Mar 2014 | - | $140.78 M(-17.3%) |
| Dec 2013 | $170.16 M(-36.2%) | $170.16 M(-8.4%) |
| Sept 2013 | - | $185.71 M(-13.7%) |
| June 2013 | - | $215.08 M(-11.2%) |
| Mar 2013 | - | $242.21 M(-9.2%) |
| Dec 2012 | $266.68 M | $266.68 M(+5.5%) |
| Sept 2012 | - | $252.76 M(+3.2%) |
| June 2012 | - | $244.90 M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $268.97 M(-9.6%) |
| Dec 2011 | $297.57 M(+20.5%) | $297.57 M(+75.6%) |
| Sept 2011 | - | $169.48 M(-12.7%) |
| June 2011 | - | $194.19 M(-11.5%) |
| Mar 2011 | - | $219.32 M(-11.2%) |
| Dec 2010 | $247.02 M(+50.8%) | $247.02 M(-8.1%) |
| Sept 2010 | - | $268.85 M(-8.9%) |
| June 2010 | - | $295.04 M(-7.5%) |
| Mar 2010 | - | $318.90 M(+94.7%) |
| Dec 2009 | $163.79 M(-11.7%) | $163.79 M(+26.6%) |
| Sept 2009 | - | $129.42 M(-12.0%) |
| June 2009 | - | $147.11 M(-11.3%) |
| Mar 2009 | - | $165.82 M(-10.6%) |
| Dec 2008 | $185.58 M(-27.6%) | $185.58 M(-7.1%) |
| Sept 2008 | - | $199.68 M(-8.6%) |
| June 2008 | - | $218.46 M(-8.1%) |
| Mar 2008 | - | $237.80 M(-7.2%) |
| Dec 2007 | $256.30 M(+199.8%) | $256.30 M(-3.4%) |
| Sept 2007 | - | $265.39 M(+232.0%) |
| June 2007 | - | $79.94 M(+15.8%) |
| Mar 2007 | - | $69.00 M(-19.3%) |
| Dec 2006 | $85.50 M(-0.4%) | $85.50 M(+56.5%) |
| Sept 2006 | - | $54.65 M(-11.6%) |
| June 2006 | - | $61.85 M(-19.6%) |
| Mar 2006 | - | $76.93 M(-10.3%) |
| Dec 2005 | $85.80 M(-29.4%) | $85.80 M(+7.4%) |
| Sept 2005 | - | $79.85 M(-15.0%) |
| June 2005 | - | $93.90 M(-13.4%) |
| Mar 2005 | - | $108.40 M(-10.9%) |
| Dec 2004 | $121.59 M(-26.8%) | $121.59 M(-0.3%) |
| Sept 2004 | - | $121.99 M(-10.5%) |
| June 2004 | - | $136.30 M(-10.8%) |
| Mar 2004 | - | $152.78 M(-8.1%) |
| Dec 2003 | $166.22 M(-2.2%) | $166.22 M(-6.9%) |
| Sept 2003 | - | $178.49 M(+27.2%) |
| June 2003 | - | $140.32 M(-9.7%) |
| Mar 2003 | - | $155.32 M(-8.6%) |
| Dec 2002 | $169.90 M(-22.2%) | $169.90 M(-6.1%) |
| Sept 2002 | - | $181.00 M(-7.2%) |
| June 2002 | - | $195.13 M(-5.6%) |
| Mar 2002 | - | $206.77 M(-5.3%) |
| Dec 2001 | $218.37 M(+5.2%) | $218.37 M(-3.8%) |
| Sept 2001 | - | $226.96 M(+16.1%) |
| June 2001 | - | $195.55 M(-3.5%) |
| Mar 2001 | - | $202.54 M(-2.5%) |
| Dec 2000 | $207.63 M(+2458.9%) | $207.63 M(-2.2%) |
| Sept 2000 | - | $212.19 M(+1.0%) |
| June 2000 | - | $210.07 M(+2977.2%) |
| Mar 2000 | - | $6.83 M |
| Dec 1999 | $8.11 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual shareholders equity year-on-year change?
- What is Lexicon Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Lexicon Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of LXRX is $93.11 M
What is the all time high annual shareholders equity for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual stockholders equity is $297.57 M
What is Lexicon Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, LXRX annual stockholders equity has changed by -$24.01 M (-20.50%)
What is Lexicon Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of LXRX is $178.51 M
What is the all time high quarterly shareholders equity for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly stockholders equity is $318.90 M
What is Lexicon Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, LXRX quarterly stockholders equity has changed by +$39.00 M (+27.96%)